PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial.
about
Other targeted drugs in melanomaA phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumorsDetection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.Tumor angiogenesis and vascular normalization: alternative therapeutic targets.Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure.Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
P2860
Q26775594-B1071B43-79A4-411B-A949-03ED56C1BF48Q33431483-A7FA330F-30ED-41B4-9DEE-591B2799E9C6Q38711439-59AF641E-AF52-4BF1-B64B-714F3018D2DBQ39403862-BB24234B-FC56-4D93-A890-711D44158C73Q41900072-152D426B-F4B4-40C3-A031-D88A7B9ACAE0Q47779611-CC567050-5D42-4D6C-9662-4C4CC28D21DAQ57106445-762AF434-2F34-4D71-9A87-35F99C718549
P2860
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PF-03446962, a fully-human mon ...... , single-group, phase 2 trial.
@ast
PF-03446962, a fully-human mon ...... , single-group, phase 2 trial.
@en
type
label
PF-03446962, a fully-human mon ...... , single-group, phase 2 trial.
@ast
PF-03446962, a fully-human mon ...... , single-group, phase 2 trial.
@en
prefLabel
PF-03446962, a fully-human mon ...... , single-group, phase 2 trial.
@ast
PF-03446962, a fully-human mon ...... , single-group, phase 2 trial.
@en
P2093
P2860
P50
P1476
PF-03446962, a fully-human mon ...... l, single-group, phase 2 trial
@en
P2093
A M Gianni
E Togliardi
M Maffezzini
P Giannatempo
P2860
P2888
P304
P356
10.1007/S10637-014-0074-9
P50
P577
2014-02-26T00:00:00Z
P6179
1048084382